| Budget Amount *help |
¥15,080,000 (Direct Cost: ¥11,600,000、Indirect Cost: ¥3,480,000)
Fiscal Year 2011: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2009: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
|
|---|
| Research Abstract |
This study aims to generate transgenic pigs expressing human ABO blood group antigens by using nuclear transfer method, and utilize the pigs to develop a novel tolerance induction method to control the rejection in ABO-incompatible transplantation. First, transgenic pig carrying one of the two glycosyltransferase genes to be transferred was produced, and then the second glycosyltransferase gene was transferred to the somatic cells of the transgenic pig. Using the genetically-engineered cells as a donor cell for nuclear transfer, purposed transgenic pig was produced. There has been seen some problems in the growth after birth and the expression of the purposed antigen, therefore additional studies are ongoing to solve the problems.
|
